Showing results (1-10 of 98) with videos related to
Sort By:
Pageof 10
Current Hematologic Malignancy Reports|April 29, 2010
Prognosis in myelodysplastic syndromes: are the new classifications useful?Naomi Galili, Azra RazaBest Practice & Research. Clinical Haematology|August 25, 2009
Clinical implications of gene expression profiling in myelodysplastic syndromes: recognition of ribosomal and translational gene dysregulation and development of predictive assaysNaomi Galili, Azra RazaNature Reviews. Cancer|November 24, 2012
The genetic basis of phenotypic heterogeneity in myelodysplastic syndromesAzra Raza, Naomi GaliliExpert Opinion on Investigational Drugs|June 22, 2006
Immunomodulatory drugs in myelodysplastic syndromesNaomi Galili, Azra RazaExpert Opinion on Pharmacotherapy|May 22, 2010
Pharmacotherapy of myelodysplastic syndromesNaomi Galili, Azra RazaTrends in Immunology|March 30, 2002
Defining the dynamics of self-assembled Fas-receptor activationSuneel D Mundle, Azra RazaMolecular & Cellular Oncology|November 19, 2016
Two different "tales" of ATG7: Clinical relevance to myelodysplastic syndromesAbdullah M Ali, Azra RazaCancers|April 13, 2024
scRNAseq and High-Throughput Spatial Analysis of Tumor and Normal Microenvironment in Solid Tumors Reveal a Possible Origin of Circulating Tumor Hybrid CellsAbdullah Mahmood Ali, Azra RazaCurrent Treatment Options in Oncology|July 20, 2007
Current treatment options: impact of cytogenetics on the course of myelodysplasiaNaomi Galili, Jan Cerny, Azra RazaBlood Reviews|December 6, 2011
MDS: Refining existing therapy through improved biologic insightsJordan Schecter, Naomi Galili, Azra RazaPageof 10